586199585	586199585	CD	B-NP	O
|	|	NN	I-NP	O
KLCBEH	KLCBEH	NN	I-NP	O
|	|	NN	I-NP	O
42767329	42767329	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0920104	0920104	CD	B-NP	O
|	|	CC	I-NP	O
6/10/2005	6/10/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
tremor	tremor	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/10/2005	6/10/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/10/2005	11/10/2005	CD	B-NP	O
******	******	SYM	I-NP	O
INCOMPLETE	INCOMPLETE	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
RINGHAND	RINGHAND	NNP	B-NP	O
,	,	,	O	O
ISMAEL	ISMAEL	NNP	B-NP	O
R	R	NNP	I-NP	O
352-37-57-2	352-37-57-2	CD	I-NP	O
Tlau	Tlau	NNP	I-NP	O
Lo	Lo	NNP	I-NP	O
Poau	Poau	NNP	I-NP	O
,	,	,	O	O
Wisconsin	Wisconsin	NNP	B-NP	O
57220	57220	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
7/5/05	7/5/05	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DEPIETRO	DEPIETRO	NNP	B-NP	O
,	,	,	O	O
RUSTY	RUSTY	NNP	B-NP	O
ABDUL	ABDUL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	NNP	B-NP	O
code	code	VBP	B-VP	O
Incomplete	Incomplete	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
CEFTRIAXONE	CEFTRIAXONE	NN	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
MG	MG	NN	I-NP	O
IV	IV	CD	B-NP	O
QD	QD	NN	I-NP	O
DIGOXIN	DIGOXIN	NN	I-NP	O
0.25	0.25	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QOD	QOD	NN	I-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QOD	QOD	NNP	I-NP	O
ISORDIL	ISORDIL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
DINITRATE	DINITRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
PRIMIDONE	PRIMIDONE	NN	I-NP	O
50	50	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
VANCOMYCIN	VANCOMYCIN	NN	I-NP	O
HCL	HCL	NN	I-NP	O
1	1	CD	I-NP	O
GM	GM	NNP	I-NP	O
IV	IV	CD	I-NP	O
Q36H	Q36H	NN	I-NP	O
Starting	Start	VBG	B-VP	O
STAT	STAT	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
5/3	5/3	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	O
instructs	instruct	NNS	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

NORVASC	NORVASC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

LOVENOX	LOVENOX	NN	B-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ENOXAPARIN	ENOXAPARIN	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
30	30	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
COREG	COREG	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
CARVEDILOL	CARVEDILOL	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
25	25	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
90	90	CD	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	O
<	<	SYM	B-VP	O
50	50	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Take	Take	VB	B-VP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
FLOMAX	FLOMAX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
TAMSULOSIN	TAMSULOSIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7	7	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QD	QD	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC	AC	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
17	17	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/13	11/13	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
RETURN	RETURN	NNP	I-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
1	1	CD	I-NP	O
week	week	NN	I-NP	O
after	after	IN	B-PP	O
d/c	d/c	NN	B-NP	O
from	from	IN	B-PP	O
rehab	rehab	NN	B-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
r/o	r/o	NN	B-NP	O
MI	MI	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
tremor	tremor	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dm	dm	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
afib	afib	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
bph	bph	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
benign	benign	JJ	I-NP	O
prostatic	prostatic	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gerd	gerd	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gastroesophageal	gastroesophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hiatal	hiatal	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
hiatal	hiatal	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
djd	djd	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
degenerative	degenerative	JJ	I-NP	O
joint	joint	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pmr	pmr	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
polymyalgia	polymyalgia	NN	I-NP	O
rheumatica	rheumatica	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
diverticulitis	diverticulitis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diverticulitis	diverticulitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
AAA	AAA	NN	I-NP	O
repair	repair	NN	I-NP	O
1994	1994	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
10	10	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
88	88	CD	B-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
man	man	NN	I-NP	O
who	who	WP	B-NP	O
comes	come	VBZ	B-VP	O
in	in	RP	B-PRT	O
from	from	IN	B-PP	O
rehab	rehab	NN	B-NP	O
with	with	IN	B-PP	O
?	?	.	O	O

hypothermia	hypothermia	NN	B-NP	O
and	and	CC	I-NP	O
rigors	rigor	NNS	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
weeks	week	NNS	I-NP	O
ago	ago	IN	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
finger	finger	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
placed	place	VBD	B-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
abx	abx	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
tail	tail	NN	I-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
he	he	PRP	B-NP	O
spiked	spike	VBD	B-VP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
VOWH	VOWH	NN	B-NP	B-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
was	be	VBD	B-VP	O
extended	extend	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	I-VP	O
rehab	rehab	VB	I-VP	O
on	on	IN	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
and	and	CC	I-NP	O
vanc	vanc	NN	I-NP	O
.	.	.	O	O

Today	Today	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
``	``	``	O	O
shaking	shake	VBG	B-VP	O
''	''	''	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
staff	staff	NN	I-NP	O
was	be	VBD	B-VP	O
concerned	concern	VBN	I-VP	O
for	for	IN	B-PP	O
rigors	rigor	NNS	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
says	say	VBZ	B-VP	O
his	his	PRP$	B-NP	O
hands	hand	NNS	I-NP	O
were	be	VBD	B-VP	O
just	just	RB	I-VP	O
quivering	quiver	VBG	I-VP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
temp	temp	NN	I-NP	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	O
was	be	VBD	B-VP	O
92	92	CD	B-NP	O
degrees	degree	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
complaining	complain	VBG	I-VP	O
of	of	IN	B-PP	O
further	further	JJ	B-NP	O
chills	chill	NNS	I-NP	O
or	or	CC	I-NP	O
rigors	rigor	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
demonstrated	demonstrate	VBD	B-VP	O
new	new	JJ	B-NP	O
ST	ST	JJ	I-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
V3-V5	V3-V5	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
CP/N/SOB	CP/N/SOB	NN	I-NP	B-protein
/	/	SYM	B-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
first	first	JJ	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
aspirin	aspirin	NN	B-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
AFib	AFib	NN	B-NP	O
,	,	,	O	O
PMR	PMR	NN	B-NP	B-protein
,	,	,	O	O
BPH	BPH	NN	B-NP	O
,	,	,	O	O
DJD	DJD	NN	B-NP	O
,	,	,	O	O
hiatal	hiatal	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
.	.	.	O	O

AAA	AAA	NN	B-NP	O
repair	repair	NN	I-NP	O
and	and	CC	O	O
sigmoid	sigmoid	JJ	B-NP	O
colectomy	colectomy	NN	I-NP	O
All	All	DT	B-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	O
Medications	Medication	NNS	I-NP	O
on	on	IN	B-PP	O
Admission	Admission	NN	B-NP	O
:	:	:	O	O
Lasix	Lasix	NN	B-NP	O
20	20	CD	I-NP	O
qod	qod	NN	I-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
40	40	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Prednisone	Prednisone	NN	B-NP	O
2	2	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Primidone	Primidone	NN	B-NP	O
50	50	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Norvasc	Norvasc	NN	B-NP	O
5	5	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Coreg	Coreg	NN	B-NP	O
25	25	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Flomax	Flomax	NN	B-NP	O
0.4	0.4	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Prilosec	Prilosec	NNP	B-NP	O
OTC	OTC	NNP	I-NP	O
20	20	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
20	20	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
ISS	ISS	NNP	B-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
7	7	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Novolog	Novolog	NNP	B-NP	O
17	17	CD	I-NP	O
qac	qac	NN	I-NP	O
,	,	,	O	O
Lovenox	Lovenox	NN	B-NP	O
30	30	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Vancomycin	Vancomycin	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
gm	gm	NN	I-NP	O
qod	qod	NN	I-NP	O
,	,	,	O	O
Ceftriaxone	Ceftriaxone	NN	B-NP	O
2	2	CD	I-NP	O
gm	gm	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Digoxin	Digoxin	NN	B-NP	O
0.25	0.25	CD	I-NP	O
qod	qod	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
bid	bid	NN	I-NP	O
Medications	Medication	NNS	I-NP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
:	:	:	O	O
NS	NS	NN	B-NP	O
500	500	CD	I-NP	O
cc	cc	NN	I-NP	O
,	,	,	O	O
Aspirin	Aspirin	NN	B-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
97.2	97.2	CD	B-NP	O
150/70	150/70	CD	I-NP	O
76	76	CD	I-NP	O
14	14	CD	I-NP	O
97	97	CD	I-NP	O
RA	RA	NN	I-NP	O
elderly	elderly	JJ	B-ADJP	O
,	,	,	O	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
NCAT	NCAT	NN	B-NP	B-protein
,	,	,	O	O
JVP	JVP	NN	B-NP	O
flat	flat	JJ	B-ADJP	O
,	,	,	O	O
CTAB	CTAB	NN	B-NP	B-protein
,	,	,	O	O
RRR	RRR	NN	B-NP	O
3/6	3/6	CD	I-NP	O
SEM	SEM	NN	I-NP	O
at	at	IN	B-PP	O
RUSB	RUSB	NNP	B-NP	O
,	,	,	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
NT/ND	NT/ND	NN	I-NP	B-protein
,	,	,	O	O
guiac	guiac	JJ	B-NP	O
neg	neg	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
C/C/E	C/C/E	NN	I-NP	B-protein
,	,	,	O	O
fine	fine	JJ	B-NP	O
tremor	tremor	NN	I-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
hands	hand	NNS	I-NP	O
-LRB-	-LRB-	MD	B-VP	O
not	not	RB	I-VP	O
pill	pill	VB	I-VP	O
rolling	roll	VBG	I-VP	O
-RRB-	-RRB-	JJ	B-NP	B-protein
CN	CN	NN	I-NP	I-protein
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
rashes	rash	NNS	I-NP	O
***	***	SYM	B-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
new	new	JJ	B-NP	O
ST	ST	JJ	I-NP	O
depressions	depression	NNS	I-NP	O
laterally	laterally	RB	B-ADVP	O
with	with	IN	B-PP	O
TWI	TWI	NN	B-NP	O
,	,	,	O	O
remained	remain	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
through	through	IN	B-PP	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
Labs	Lab	NNS	I-NP	O
:	:	:	O	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
negative	negative	JJ	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
x	x	SYM	B-NP	O
3	3	CD	B-NP	O
***	***	SYM	I-NP	O
Hospital	Hospital	NN	I-NP	O
Course	Course	NN	I-NP	O
:	:	:	O	O
CV	CV	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
3	3	CD	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
negative	negative	JJ	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
remained	remain	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
clear	clear	JJ	B-ADJP	O
how	how	WRB	B-ADJP	O
old	old	JJ	I-ADJP	O
these	these	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
recommend	recommend	VBP	B-VP	O
outpatient	outpatient	NN	B-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
and	and	CC	O	O
cardiology	cardiology	NN	B-NP	O
follow-up	follow-up	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
bradycardic	bradycardic	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hi	hi	NN	I-NP	O
30s	30s	CD	I-NP	O
overnight	overnight	NN	I-NP	O
without	without	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
A	A	DT	B-NP	O
Fib	Fib	NN	I-NP	B-protein
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
junctional	junctional	JJ	B-NP	O
escape	escape	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
or	or	CC	O	O
Digoxin	Digoxin	NN	B-NP	O
toxicity	toxicity	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Digoxin	Digoxin	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
1.9	1.9	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
morning	morning	NN	I-NP	O
Coreg	Coreg	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
HR	HR	NN	I-NP	B-protein
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
50s	50	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
voiced	voice	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	I-VP	O
rehab	rehab	VB	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
A	A	NNP	I-NP	O
Fib	Fib	NNP	I-NP	O
is	be	VBZ	B-VP	O
old	old	JJ	B-ADJP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	I-VP	O
anticoagulated	anticoagulate	VBN	I-VP	O
with	with	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tremor	tremor	NN	B-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Primidone	Primidone	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Ceftriaxone	Ceftriaxone	NN	I-NP	O
and	and	CC	I-NP	O
Vancomycin	Vancomycin	NN	I-NP	O
were	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
remained	remain	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
rigors	rigor	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
further	further	JJ	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
showed	show	VBD	B-VP	O
NGTD	NGTD	NN	B-NP	B-protein
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
,	,	,	O	O
standing	stand	VBG	B-VP	O
insulin	insulin	NN	B-NP	O
qAC	qAC	NN	I-NP	O
and	and	CC	O	O
insulin	insulin	NN	B-NP	O
SS	SS	NN	I-NP	O
GU	GU	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Flomax	Flomax	NN	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
BPH	BPH	NN	I-NP	O
.	.	.	O	O

PPX	PPX	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
and	and	CC	O	O
required	require	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
.	.	.	O	O

Full	Full	NNP	B-NP	O
Code	Code	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNP	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
you	you	PRP	B-NP	O
PCP	PCP	NN	I-NP	O
within	within	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
ALLENBACH	ALLENBACH	NN	B-NP	O
,	,	,	O	O
CORDELL	CORDELL	NNP	B-NP	O
W	W	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.B.A.	M.B.A.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
EF77	EF77	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/5/05	7/5/05	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
50	50	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

